Herpes Marker Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Test Type (Nucleic Acid Amplification Test, Viral Culture Tests, Antibody-Antigen Based Tests), By Virus Type (HSV-1, HSV-2, HSV-1 & HSV-2), By Application (Clinical Diagnosis, Research Use), By End User (Hospitals, Research Laboratories, Diagnostic Centres, Others) and Region

Herpes Marker Testing Market size was valued at US$ 466.6 million in 2023 and is poised to grow at a CAGR of 4.4% during 2024-2030. Driving factors for the global herpes marker testing market include a rise in prevalence of the herpes infections across the globe. In addition, a rise in government support for the development of accurate diagnostics for diseases like herpes and growing awareness related to the available diagnostic tests for herpes are expected to boost the market growth over the forecast period. Numerous regional and international firms compete in the global market for herpes marker testing products, which is constantly evolving due to technology improvements and new product introductions.

The prevalence of herpes in the population, increased government backing, growing awareness, rising healthcare expenditures, new product introductions, and a growing focus on evidence-based medicine are all driving the herpes marker testing industry. Some obstacles are limiting market revenue growth, such as limited access to diagnostic services in rural places, insufficient R&D initiatives, pricing pressures, and severe restrictions. To stay competitive in the global market, companies are working on acquisitions, mergers, and new product approvals and launches. The market for herpes marker testing is separated into three types of tests: viral culture tests, nucleic acid amplification-based kits, and antibody/antigen-based kits. Because of the large product availability and high physician preference for this test type, the antibody/antigen-based kits segment dominates the market with over 50% market share estimated during the projection period. However, due to the increased use of PCR technique in diagnosis due to its high sensitivity, specificity, and low time consumption, the nucleic acid amplification-based kits segment is expected to develop at the fastest rate over the projection period.